Cancerworld Magazine
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
SUBSCRIBE FOR FREE
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
Cancerworld Magazine > Partnership > ECL > The past, present and future of the European Code against Cancer (ECAC)

The past, present and future of the European Code against Cancer (ECAC)

  • 30 August 2022
  • External Contributor
Total
0
Shares
0
0
0
0
0

It seems that hardly a week goes by without some media outlet reporting anxiously on the latest thing that has been linked to cancer. The average person would be forgiven for thinking that everything can cause cancer. Thankfully, far-sighted experts broughttogether by the European Commission four decades ago developed a framework to inform the public of the key things they needed to know to prevent cancer.

The European Code against Cancer (ECAC) informs people about actions they can take to reduce their cancer risk. An initiativeof the European Commission, the scientific basis for the ECAC is provided by the International Agency for Research on Cancer (WHO/IARC), marking it out as the definitive tool for cancer prevention in Europe.

The Past

Right from the start, cancer leagues have been the early adopters and primary promoters of the ECAC.

Leagues have used it to inform targeted communication to specific groups, develop health promotion interventions, and support policy recommendations at the governmental level. At the Association of European Cancer Leagues (ECL), all of
our cancer prevention work has been based on the evidence provided by each edition of ECAC.

Since 2014, ECL has acted as ECAC’s custodian, having invested considerable resources to support member leagues to use ECAC and apply its evidence to promote cancer prevention at the national and local levels. We have also empowered and trained dozens of Youth Ambassadors to disseminate ECAC amongst their peers and the wider public.

The Present

The current edition of ECAC consists of 12 simple-tounderstand messages complemented by:

  • Fourteen scientific publications describing the methodology to update ECAC and evidence for eachmessage
  • an extensive online Q&A section
  • Two sets of self-paced, multilingual e-learning modules about ECAC (available in English and French and soon in German, Hungarian, Spanish and Polish)

We encourage everyone to make use of these free resources and complete the ECAC e-learning modules to gain a certification as an ECAC promoter!

The Future

Europe’s Beating Cancer Plan demonstrates the commitment of the European Union to diminishing the negative impact of cancer on society. A key priority of the plan is the commitment to update the ECAC.

The future 5th edition represents a golden opportunity to build on past successes by expanding the scope of ECAC to incorporate new tools and materials to aid implementation and dissemination. To do so, a permanent mechanism to update the ECAC in the long term is needed.

ECL is appealing for the establishment of a robust governance model for the ECAC and calls on all stakeholders to become active promoters.

So why not join cancer leagues, WHO/IARC and the EU institutions in amplifying ECAC and, together, we can step-up cancer prevention in Europe!

Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
External Contributor

You May Also Like
View Post
  • News

Study highlights need to reanalyse genomics and genetics of metastatic tumours

  • Janet Fricker
  • 27 January 2023
View Post
  • Articles
  • Policy

The cancer patients still struggling to access drugs in the wake of anti-corruption reforms

  • Giselle Vidal
  • 27 January 2023
View Post
  • Supported contents

AI in Genomics and Reporting for Clinical Practice

  • Adriana Albini
  • 26 January 2023
View Post
  • News

Current cervical cancer screening paradigm fails older women

  • Janet Fricker
  • 26 January 2023
View Post
  • Articles
  • Delivery of Care

Immunotherapy: outcomes of ultra low-dose trial offer hope for better global access

  • Swagata Yadavar
  • 26 January 2023
View Post
  • Supported contents

Telemedicine in Cancer Care: Monitoring, Follow-Up,Tele-Rehabilitation, Palliative and Supportive Care

  • Adriana Albini
  • 23 January 2023
View Post
  • Articles
  • Policy

Cervical cancer elimination efforts boosted by simpler ways to identify and treat pre-cancerous lesions

  • Esther Nakkazi
  • 12 January 2023
View Post
  • Supported contents

AI application in diagnosis

  • Adriana Albini
  • 11 January 2023
search
or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • Study highlights need to reanalyse genomics and genetics of metastatic tumours
    • 27 January 2023
  • Current cervical cancer screening paradigm fails older women
    • 26 January 2023
  • Call-to-arms for Europe to provide essential paediatric anti-cancer medicines
    • 9 January 2023
  • Exercise-stimulated myokine production can extend survival in advanced prostate cancer
    • 9 January 2023
  • Five San Antonio take-aways to improve care of breast cancer patients
    • 16 December 2022
Article
  • The cancer patients still struggling to access drugs in the wake of anti-corruption reforms
    • 27 January 2023
  • Immunotherapy: outcomes of ultra low-dose trial offer hope for better global access
    • 26 January 2023
  • Cervical cancer elimination efforts boosted by simpler ways to identify and treat pre-cancerous lesions
    • 12 January 2023
Latest printed issue
Social

Would you follow us ?

Contents
  • AI in Genomics and Reporting for Clinical Practice
    • 26 January 2023
  • Telemedicine in Cancer Care: Monitoring, Follow-Up,Tele-Rehabilitation, Palliative and Supportive Care
    • 23 January 2023
  • AI application in diagnosis
    • 11 January 2023
MENU
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
Cancerworld Magazine
  • About the Magazine
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is funded by SPCC Sharing Progress in Cancer Care | Via Vincenzo Vela 6, 6500 Bellinzona - Switzerland | info@spcc.net

Archivio Cancerworld

Input your search keywords and press Enter.